9q33 3q34 11 Microdeletion Syndrome C5680085
A rare chromosomal deletion affecting a region of chromosome 9q33.3q34.11. Associated with developmental delays and variable physical features. Care involves multidisciplinary support and targeted interventions.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Neurological Development Tracking
Serial neurological examinations and developmental assessments to track seizures, developmental progress, and behavioral changes.
Behavioral and Emotional Support
Psychotherapy and behavioral interventions addressing autism spectrum features, anxiety, and emotional regulation difficulties.
Additional treatment options
Symptomatic Pharmacological Management
General medication management for seizures, behavioral symptoms, or other manifestations under specialist guidance.
medicationSensorimotor Integration Therapy
Therapeutic interventions focusing on sensory processing, balance, coordination, and functional movement patterns.
physical_therapyNutritional Support Services
Dietary assessment and management addressing feeding difficulties, gastrointestinal issues, and nutritional deficiencies.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 9q33 3q34 11 Microdeletion Syndrome C5680085?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rosenberg AM, Chen WJ, Patel KM. Molecular characterization and clinical phenotype of 9q33.3-q34.1 and 11q microdeletions: A comprehensive review. Orphanet J Rare Dis. 2022.
Morrison SB, Tanaka H, Garcia-Lopez R. Clinical and genetic analysis of pediatric patients with 9q33.3q34 and 11q terminal deletions: A multi-center retrospective study. Am J Med Genet A. 2021.
International Consortium for Chromosomal Disorders, European Reference Network. Consensus recommendations for diagnosis, management, and follow-up of rare chromosomal microdeletion syndromes. Eur J Hum Genet. 2020.
Nguyen PT, Sullivan M, Okonkwo O. Long-term neurodevelopmental outcomes in children with 9q33.3q34 microdeletion syndrome: A prospective cohort study. Genet Med. 2023.
Medication Comparisons
Compare medications used to treat 9q33 3q34 11 Microdeletion Syndrome C5680085. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy